Semaglutide: A Head-to-Head Bio-Better Analysis Tirzepatide is a bio-better not of the semaglutide molecule but of the GLP-1 single-receptor mechanism
77 , e108e110
O contedo essencial deste acordo est disponvel mediante pedido
Medical management options for heavy menstrual bleeding, as recommended by NICE, include: Levonorgestrel intrauterine system (LNG-IUS) : Often first-line treatment, reducing menstrual blood loss by up to 95% within 12 months Tranexamic acid : An antifibrinolytic agent taken during menstruation to reduce blood loss by 40-50% (caution if you have a history of blood clots) Non-steroidal anti-inflammatory drugs (NSAIDs) : Such as mefenamic acid, which can reduce flow by 20-30% and help with associated pain (use with caution if you have gastrointestinal, renal or cardiovascular conditions) Combined hormonal contraception : Can regulate cycles and reduce bleeding in suitable candidates Oral progestogens : Taken cyclically or continuously, depending on individual circumstances If you currently use a copper intrauterine device (IUD), this can contribute to heavier periods, and switching to a levonorgestrel IUS might be beneficial
Hitting weight loss targets
Individual variation exists, but the pattern, rough month 2, improvement month 3, minimal symptoms months 4+, holds for about 85% of patients who complete treatment
